These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9249126)

  • 61. THA increases action potential duration of central histamine neurons in vitro.
    Reiner PB; McGeer EG
    Eur J Pharmacol; 1988 Oct; 155(3):265-70. PubMed ID: 3148476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral tacrine administration in middle-aged monkeys: effects on discrimination learning.
    Fitten LJ; Perryman K; Tachiki K; Kling A
    Neurobiol Aging; 1988; 9(2):221-4. PubMed ID: 3374739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharma-clinics. Drug of the month. Tacrine (Cognex)].
    Scheen AJ
    Rev Med Liege; 1996 May; 51(5):379-81. PubMed ID: 8992561
    [No Abstract]   [Full Text] [Related]  

  • 64. Trichlorethylene in air with muscle relaxants. A reappraisal with particular reference to use in developing countries.
    Prior FN
    Anaesthesia; 1972 Jan; 27(1):66-75. PubMed ID: 4257323
    [No Abstract]   [Full Text] [Related]  

  • 65. Substituted Aminobenzothiazole Derivatives of Tacrine: Synthesis and Study on Learning and Memory Impairment in Scopolamine-Induced Model of Amnesia in Rat.
    Ahmadi A; Roghani M; Noori S; Nahri-Niknafs B
    Mini Rev Med Chem; 2019; 19(1):72-78. PubMed ID: 30009706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 68. Controlled release tacrine delivery system for the treatment of Alzheimer's disease.
    Yang Q; Williams D; Owusu-Ababio G; Ebube NK; Habib MJ
    Drug Deliv; 2001; 8(2):93-8. PubMed ID: 11400868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Resistance to D-tubocurarine of the rat diaphragm as compared to a limb muscle: influence of quantal transmitter release and nicotinic acetylcholine receptors.
    Nguyen-Huu T; Molgó J; Servent D; Duvaldestin P
    Anesthesiology; 2009 May; 110(5):1011-5. PubMed ID: 19352164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of feeding conditions on sensitivity to tubocurarine of nerve-muscle preparations from the mouse.
    Nishimura M; Asai N; Taquahashi Y; Satoh E; Shimizu Y
    Gen Pharmacol; 1997 Nov; 29(5):799-803. PubMed ID: 9347329
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Facilitation of neuromuscular transmission by anticholinesterase drugs.
    BLABER LC
    Br J Pharmacol Chemother; 1963 Feb; 20(1):63-73. PubMed ID: 13971349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of tetrahydroaminoacridine: relations to clinical and biochemical effects in Alzheimer patients.
    Ahlin A; Adem A; Junthé T; Ohman G; Nybäck H
    Int Clin Psychopharmacol; 1992; 7(1):29-36. PubMed ID: 1624754
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.
    Scaf AH; van den Akker J; Berends F
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930
    [No Abstract]   [Full Text] [Related]  

  • 74. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
    Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
    Neuroreport; 1997 May; 8(8):1845-9. PubMed ID: 9223063
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double blind comparison of pancuronium and D-tubocurarine for endotracheal intubation.
    Catton DV; Browne RA
    Can Anaesth Soc J; 1972 May; 19(3):305-8. PubMed ID: 4260447
    [No Abstract]   [Full Text] [Related]  

  • 76. Non-anticholinesterase, non-cholinergic effect of tacrine on gastrointestinal smooth muscle tissues of rat.
    Turiiski VI; Argirova MD; Krustev AD
    Folia Med (Plovdiv); 2005; 47(2):45-51. PubMed ID: 16544849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Steroid hormones mediate sex difference in brain levels of tacrine and its hypothermic effect in the rat.
    Wang RH; Weinstock M
    Neuropharmacology; 2001 Dec; 41(7):887-94. PubMed ID: 11684153
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The next generation of cholinesterase inhibitors.
    Adem A
    Acta Neurol Scand Suppl; 1993; 149():10-2. PubMed ID: 8128831
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.
    Hartvig P; Askmark H; Aquilonius SM; Wiklund L; Lindström B
    Eur J Clin Pharmacol; 1990; 38(3):259-63. PubMed ID: 2340845
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Functional and pharmacokinetic studies of tetrahydroaminoacridine in patients with amyotrophic lateral sclerosis.
    Askmark H; Aquilonius SM; Gillberg PG; Hartvig P; Hilton-Brown P; Lindström B; Nilsson D; Stålberg E; Winkler T
    Acta Neurol Scand; 1990 Oct; 82(4):253-8. PubMed ID: 2270755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.